The New York Times once called John Lamattina, then Pfizer head of R&D, “Dr. Optimistic.” He’s not so optimistic now.
Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. The pharmaceutical industry is at a significant crossroads, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback